cooper development &lt;bugs> restates results cooper development revised results year ended october 31 loss 61.7 mln dlrs, 2.33 dlrs share, previously-reported loss 12.1 mln dlrs, 46 cts share. restatement made change method accounting combination company-controlled concerns resulted 53.5 mln dlr charge, cooper development said. august cooper development combined cooper biomedical unit cooper laboratories subsidiary technicon instruments corp, company acquired revlon &lt;rev>, cooper spokesman said. spokesman transaction accounted acquisition, securities exchange commission issue accounting method accounted reorganization entities common control. treatment requires costs transaction expanded capitalized intangible asset, company said. that, charged required expensing previously accrued liabilities, company experience resulting material change cash flow.